Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05709860 · ClinicalTrials.gov registry record · NA

An Electronic Health Record-based Approach to Increase PrEP Knowledge and Uptake: the EMC2 PrEP Strategy

A NA study, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
200
Enrollment target

NCT05709860: Completed NA study, sponsored by Northwestern University.

NCT05709860 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05709860, a NA study, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target

Study Summary

This study is being conducted to investigate a strategy that may improve knowledge and uptake of pre-exposure prophylaxis for HIV prevention (PrEP) among cisgender women in primary care.

Primary Outcome

PrEP uptake will be measured during the intervention period between study arms to investigate the effects of the EMC2 PrEP strategy.

Interventions

  • BEHAVIORAL EMC2 PrEP Educational Tool
  • BEHAVIORAL Discrete Scheduling of a Dedicated PrEP Visit

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2023-11-29
Est. Completion 2024-10-29
Phase NA
Northwestern University

1,209 total trials

What the finished NCT05709860 record still lists

NCT05709860 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 2 interventions - of which EMC2 PrEP Educational Tool is the first listed.

NCT05709860 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05709860 about?

NCT05709860 is a clinical study titled "An Electronic Health Record-based Approach to Increase PrEP Knowledge and Uptake: the EMC2 PrEP Strategy". This study is being conducted to investigate a strategy that may improve knowledge and uptake of pre-exposure prophylaxis for HIV prevention (PrEP) among cisgender women in primary care.

What is the current status of trial NCT05709860?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2023-11-29. Estimated completion is 2024-10-29.

What interventions are being tested in trial NCT05709860?

The interventions under investigation include: EMC2 PrEP Educational Tool (BEHAVIORAL), Discrete Scheduling of a Dedicated PrEP Visit (BEHAVIORAL).

Who is sponsoring clinical trial NCT05709860?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05709860's enrollment target sits among peer trials

200 506th of 2000 higher than 1,434 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05709860, the US trial registry maintained by the National Library of Medicine. NCT05709860 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.